A double-blind, placebo-comparison study to evaluate the efficacy and safety of ACTIQ (oral transmucosal fentanyl citrate [OTFC]) treatment for opioid-tolerant children and adolescents with breakthrough [cancer] pain
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2014
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Cephalon
- 25 May 2007 Status change from in progress to completed.
- 28 Aug 2006 Status change
- 15 Nov 2005 New trial record.